| Catalog No. |
TD-HS856206 |
| Species reactivity |
Human |
| Applications |
Research Grade Biosimilar |
| Host species |
Humanized |
| Isotype |
IgG1(VH-CH1-h)-scFv_L-kappa-scFv |
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, IL17F, Interleukin-17F, IL-17F, Cytokine ML-1, IL13, NC30, Interleukin-13, IL-13, ALB, Albumin |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G, purified from cell culture supernatant. |
| Accession |
Q16552, Q96PD4 & P35225 & P02768 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS,pH7.4. |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names |
Trispecific,Trivalent,CAS:2648456-30-6 |
| Background |
Galvokimig is an anti-IL13/IL17A/ALB/IL17B monoclonal antibody. |
| Note |
For research use only. Not for use in clinical or therapeutic applications. |